Analysts Are Bullish on Top Healthcare Stocks: Cellectis SA (CLLS), VBI Vaccines (VBIV)


There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cellectis SA (CLLS) and VBI Vaccines (VBIV) with bullish sentiments.

Cellectis SA (CLLS)

Oppenheimer analyst Hartaj Singh maintained a Buy rating on Cellectis SA today. The company’s shares opened today at $19.50.

According to TipRanks.com, Singh is a 3-star analyst with an average return of 3.1% and a 47.0% success rate. Singh covers the Healthcare sector, focusing on stocks such as Strongbridge Biopharma Plc, Catabasis Pharmaceuticals, and Actinium Pharmaceuticals.

Currently, the analyst consensus on Cellectis SA is a Strong Buy with an average price target of $37.25, implying a 91.0% upside from current levels. In a report issued on March 11, Barclays also maintained a Buy rating on the stock with a $50 price target.

See today’s analyst top recommended stocks >>

VBI Vaccines (VBIV)

Oppenheimer analyst Leland Gershell maintained a Buy rating on VBI Vaccines today. The company’s shares opened today at $1.98.

According to TipRanks.com, Gershell is a 2-star analyst with an average return of 1.0% and a 54.0% success rate. Gershell covers the Healthcare sector, focusing on stocks such as Anchiano Therapeutics Ltd, Avenue Therapeutics Inc, and Evofem Biosciences Inc.

VBI Vaccines has an analyst consensus of Moderate Buy.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts